Dynamic Plasticity of Prostate Cancer Intermediate Cells During Androgen Receptor-Targeted Therapy

The authors identified steady-state transcriptional heterogeneity in androgen receptor and neuroendocrine biomarkers, including intermediate subpopulations that are coordinately high for prostate-specific antigen and neuron-specific enoclase promoter activity.
[Cell Reports]
Full ArticleGraphical Abstract

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News